During the last decade many of you gave us ideas, suggestions and critiques to advance our immunotherapy technologies and products. The result is a comprehensive peptide-based product and service portfolio for both cellular and humoral immunity.
Our newly designed Immunology Brochure contains new products, services & features, it encourages you to get in touch with our technical support team to discuss your specific peptide needs ranging from neo-epitope qualification and immune monitoring to peptide-based therapies.
Please find recent additions among the following product lines:
- GxP Peptides fulfilling highest standards for immunotherapy
- TERS™ T-Cell Assay Standardization Kits
- PepTrack™ Fast Track Libraries for fast neo-epitope prioritization & target discovery
- PepMix™ Peptide Pools for immune monitoring & adoptive therapy
- PepStar™ Peptide Arrays for seroprofiling & epitope discovery
Below are examples of recent papers that use our products:
A Single Exercise Bout Enhances the Manufacture of Viral-Specific T-cells from Healthy Donors: Implications for Allogeneic Adoptive Transfer Immunotherapy
G. Spielmann, C.M. Bollard, H. Kunz et al., Sci Rep (2016) - PMID: 27181409
Deletion of A44L, A46R and C12L Vaccinia Virus Genes from the MVA Genome Improved the Vector Immunogenicity by Modifying the Innate Immune Response Generating Enhanced and Optimized Specific T-Cell Responses
María Pía Holgado, Juliana Falivene, Cynthia Maeto et al., Viruses (2016) - PMID: 27223301
Efficacy and Safety of a Preemptive Antiviral Therapy Strategy Based on Combined Virological and Immunological Monitoring for Active Cytomegalovirus Infection in Allogeneic Stem Cell Transplant Recipients
David Navarro, Paula Amat, Rafael de la Cámara et al., Oxford Jounals (2016)
A Phase I Study of Recombinant (r) Vaccinia-CEA (6D)-TRICOM and rFowlpox-CEA (6D)-TRICOM Vaccines with GM-CSF and IFN-α-2b in Patients with CEA-expressing carcinomas
Duggan MC, Jochems C, Donahue RN et al., Immunother. (2016) - PMID: 27581603
Human Parainfluenza Virus-3 can be Targeted by Rapidly Ex Vivo Expanded T Lymphocytes
McLaughlin LP, Lang H, Williams E et al., Cytotherapy (2016) - PMID: 27692559
Find more publications here!
Happy reading and please contact us with your comments and questions!